期刊文献+

腹膜透析相关性腹膜炎的致病菌谱和耐药性分析 被引量:5

Analysis of Pathogenic Bacteria Spectrum and Drug Resistance in Patients with Peritoneal Dialysis Associated Peritonitis
下载PDF
导出
摘要 目的通过对腹膜透析相关性腹膜炎的致病菌谱和耐药性分析,为临床合理用药提供科学依据。方法回顾性分析成都医学院第一附属医院肾病科2013年8月至2017年8月收治腹膜透析相关性腹膜炎的临床资料。结果共纳入腹膜透析相关性腹膜炎122例次,病原菌培养阳性84例次(68.85%),共检出菌株88株,包括G+菌63株,G-菌21株,真菌3株,抗酸杆菌1株。G+菌以表皮葡萄球菌最常见,G-菌以大肠埃希菌最常见。G+菌对万古霉素、利奈唑胺、替加环素均敏感,对头孢唑林的耐药率为42.86%。G-菌对美罗培南、莫西沙星、哌拉西林/他唑巴坦、头孢噻肟均敏感,对头孢唑肟的耐药率为12.50%。结论腹膜透析相关性腹膜炎的致病菌及耐药性已发生很大变化,虽然G+菌仍为主要致病菌,但头孢唑林已不再适合经验性治疗,可考虑选择万古霉素。 Objective To Investigate the pathogenic bacteria spectrum and drug resistance in patients with peritoneal dialysis associated peritonitis (PDAP) in order to provide the scientific basis for the clinical rational use of drugs. Methods The clinical data of the PDAP patients treated from August of 2013 to August of 2017 in The First Affiliated Hospital of Chengdu Medical College were analyzed retrospectively. Results A total of 122 cases with PDAP were enrolled into this study. There were 84 cases of positive pathogenic bacteria culture accounting for 68.85%, in which there were a total of 88 bacterial strains including 63 strains of gram-positive bacteria, 21 strains of gram-negative bacteria, 3 strains of fungus and 1 strain of acid-fast bacilli. Staphylococcus epidermidis was the most common in the gram-positive bacteria, while Escherichia coli was the most common in the gram-negative bacteria. The gram-positive isolates were all sensitive to vancomycin, linezolid and tigecycline, and the rate of the drug resistance to cefazolin was 42.86%. The gram-negative isolates were all sensitive to meropenem, moxifloxacin, piperacillin/tazobactam and cefotaxime, and the rate of the drug resistance to ceftizoxime was 12.50%. Conclusion The pathogenic bacteria and drug resistance in patients with PDAP have been changed markedly. The gram-positive bacteria is the common pathogenic bacteria in patients with PDAP, but cefazolin is no longer suitable for the empirical treatment and vancomycin can be considered as the substitute.
作者 赖玮婧 黄艾晶 高芳 王少清 Lai Weijing;Huang Aijing;Gao Fang;Wang Shaoqing(Department of Nephrology,The First Affiliated Hospital of Chengdu Medical College,Chengdu 610500,China)
出处 《成都医学院学报》 CAS 2018年第5期612-615,620,共5页 Journal of Chengdu Medical College
关键词 腹膜透析 腹膜炎 致病菌 耐药性 Peritoneal dialysis Peritonitis Pathogenic bacteria Drug resistance
  • 相关文献

参考文献6

二级参考文献50

  • 1郭群英,陈林,阳晓,杨念生,冯敏,姜宗培,毛海萍,陈崴,余学清.腹膜透析相关感染性腹膜炎致病菌及菌谱变化——单个腹膜透析中心15年回顾分析[J].中华肾脏病杂志,2006,22(12):719-724. 被引量:64
  • 2倪军,童孟立,崔杏成.72例次持续性非卧床腹透腹膜炎分析[J].中国中西医结合肾病杂志,2007,8(4):217-219. 被引量:24
  • 3冯敏,郭群英,余学清,陈冬梅,阳晓,姜宗培,毛海萍,陈崴,董秀清,傅君舟,李剑文,陈林.提高腹膜透析相关感染性腹膜炎致病菌培养阳性率的方法学研究[J].中华肾脏病杂志,2007,23(6):345-350. 被引量:15
  • 4Piraino B,Bailie GR,Bernardini J,et al.ISPD Ad Hoc Advisory Committee:Peritoneal dialysis-related infections recommendations:2005 update.Perit Dial Int,2005,25:107-131.
  • 5Saito T,Iinuma Y,Takakura S, et al.Can BacT/Alert FA and FN blood culture bottles increase the recovery of microorganisms in the clinical laboratory. J Infect Chemother,2004, 10:343-347.
  • 6Coffin E,Pouthier D,Poehet JM,et al.Vancomycin and eiprofloxacin:systemic adtibiotic administration for peritoneal dialysis associated peritonitis.Perit Dial Int,2004,24:416-418.
  • 7Ronco C,Crepaldi C,Cruz DN.Peritoneal dialysis from basic concepts to clinical excellence. Contrib Nephrol (Basel,Karger),2009,163:161-168.
  • 8Nessim SJ. Prevention of dialysis-related infections [J]. Semin Nephrol , 2011. 31(4): 199-212.
  • 9Li PK. Szeto ce. Piraino B. et al. Peritoneal dialysis-related infections recommendations: 2010 updateDJ. Perit Dial Int. 2010. 30(5): 393-423.
  • 10Piraino B. Bailie GR. Bernardini J. et al. Peritoneal dialysisrelated infections recommendations: 2005 update[J]. Perit Dial Int. 2005. 25(2): 107-131.

共引文献67

同被引文献54

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部